A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
COVID-19 Bivalent Boosters | Johns Hopkins | Bloomberg School of Public Health
Evidence to recommendation Framework: Bivalent COVID-19 vaccine booster doses
CDC publishes first estimates of bivalent boosters' effectiveness against XBB.1.5
FDA clears the way for additional bivalent boosters for certain vulnerable individuals | CNN
A quick update on the bivalent boosters - by Eric Topol
FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN
Updated COVID boosters give significant protection, data show - Los Angeles Times
Studies show real-world usefulness of bivalent COVID boosters | CIDRAP
Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada | medRxiv
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
NEJM on X: "Figure 1. Effectiveness of Bivalent Boosters According to the Interval since Administration. https://t.co/hIVtIujZoq #Covid19 https://t.co/KBljA6y7NR" / X
How Effective Are the Bivalent Boosters? CDC Shares New Data
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study - The Lancet Infectious Diseases
COVID-19 bivalent booster effectiveness in people with and without immune dysfunction L
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Effectiveness of Vaccination and Previous Infection Against Omicron Infection and Severe Outcomes in Children Under 12 Years of Age | medRxiv
Bivalent COVID-19 mRNA Booster Effective - Southern Iowa Mental Health Center
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population | Nature Medicine
Updated COVID-19 booster targets subvariants responsible for 98% of cases today : Oregon Health News Blog
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ